Fig. 6.
Nonmyeloablative bone marrow transplantation with213Bi–anti-CD45 mAb and MMF-CSP.
Treatment scheme, hematologic values, and microsatellite marker studies of chimerism in dog E889, which was given a transplant of marrow from the DLA-identical littermate E886 after conditioning with 4.6 mCi/kg (170 MBq/kg) 213Bi–anti-CD45 mAb and MMF-CSP for posttransplantation immunosuppression.